Saudi Pharmaceutical Industries and Medical Appliances Future Growth
Future criteria checks 4/6
Saudi Pharmaceutical Industries and Medical Appliances is forecast to grow earnings and revenue by 41.2% and 10.2% per annum respectively. EPS is expected to grow by 68% per annum. Return on equity is forecast to be 13.3% in 3 years.
Key information
41.2%
Earnings growth rate
68.0%
EPS growth rate
| Pharmaceuticals earnings growth | 17.7% |
| Revenue growth rate | 10.2% |
| Future return on equity | 13.3% |
| Analyst coverage | Low |
| Last updated | 23 Apr 2024 |
Recent future growth updates
Recent updates
Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Not Lagging Industry On Growth Or Pricing
Mar 21
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Worth ر.س38.1 Based On Its Intrinsic Value?
Jun 26Is There An Opportunity With Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) 20% Undervaluation?
Mar 14Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Intrinsic Value Is Potentially 52% Above Its Share Price
Aug 02Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Dividend Is Being Reduced To ر.س0.60
May 19One Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) Analyst Just Made A Major Cut To Next Year's Estimates
May 12A Look At The Fair Value Of Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Feb 20Saudi Pharmaceutical Industries and Medical Appliances' (TADAWUL:2070) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 18Does It Make Sense To Buy Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) For Its Yield?
Mar 30Should Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) Be Disappointed With Their 50% Profit?
Feb 23What You Need To Know About Saudi Pharmaceutical Industries and Medical Appliances Corporation's (TADAWUL:2070) Investor Composition
Jan 19
Is Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070) At Risk Of Cutting Its Dividend?
Dec 16Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,414 | 268 | N/A | N/A | 2 |
| 12/31/2025 | 2,138 | 154 | 117 | 163 | 4 |
| 12/31/2024 | 1,916 | 82 | 87 | 127 | 4 |
| 12/31/2023 | 1,653 | -20 | -70 | 48 | N/A |
| 9/30/2023 | 1,692 | -71 | -44 | 30 | N/A |
| 6/30/2023 | 1,667 | -75 | -85 | -18 | N/A |
| 3/31/2023 | 1,569 | -144 | -246 | -170 | N/A |
| 12/31/2022 | 1,422 | -152 | -178 | -99 | N/A |
| 9/30/2022 | 1,425 | -94 | -195 | -109 | N/A |
| 6/30/2022 | 1,379 | -42 | -229 | -136 | N/A |
| 3/31/2022 | 1,394 | 38 | -10 | 73 | N/A |
| 12/31/2021 | 1,460 | 30 | 9 | 87 | N/A |
| 9/30/2021 | 1,471 | 57 | -102 | 18 | N/A |
| 6/30/2021 | 1,532 | 117 | -145 | -24 | N/A |
| 3/31/2021 | 1,534 | 110 | -172 | -23 | N/A |
| 12/31/2020 | 1,555 | 130 | -165 | 10 | N/A |
| 9/30/2020 | 1,521 | -114 | 44 | 278 | N/A |
| 6/30/2020 | 1,491 | -153 | 241 | 505 | N/A |
| 3/31/2020 | 1,518 | -365 | -37 | 275 | N/A |
| 12/31/2019 | 1,487 | -434 | 18 | 352 | N/A |
| 9/30/2019 | 1,743 | -163 | -164 | 138 | N/A |
| 6/30/2019 | 1,626 | -204 | -461 | -165 | N/A |
| 3/31/2019 | 1,566 | 6 | -271 | 10 | N/A |
| 12/31/2018 | 1,503 | 74 | -355 | -74 | N/A |
| 9/30/2018 | 1,313 | 66 | -280 | -42 | N/A |
| 6/30/2018 | 1,366 | 61 | -220 | 25 | N/A |
| 3/31/2018 | 1,375 | 85 | -99 | 103 | N/A |
| 12/31/2017 | 1,386 | 139 | -79 | 155 | N/A |
| 9/30/2017 | 1,315 | 274 | N/A | 205 | N/A |
| 6/30/2017 | 1,295 | 296 | N/A | 118 | N/A |
| 3/31/2017 | 1,329 | 289 | N/A | -21 | N/A |
| 12/31/2016 | 1,259 | 277 | N/A | -94 | N/A |
| 9/30/2016 | 1,448 | 124 | N/A | -281 | N/A |
| 6/30/2016 | 1,499 | 149 | N/A | -134 | N/A |
| 3/31/2016 | 1,595 | 347 | N/A | -53 | N/A |
| 12/31/2015 | 1,705 | 357 | N/A | -38 | N/A |
| 9/30/2015 | 1,604 | 457 | N/A | 115 | N/A |
| 6/30/2015 | 1,562 | 465 | N/A | 44 | N/A |
| 3/31/2015 | 1,500 | 325 | N/A | 12 | N/A |
| 12/31/2014 | 1,470 | 317 | N/A | 43 | N/A |
| 9/30/2014 | 1,424 | 283 | N/A | -94 | N/A |
| 6/30/2014 | 1,381 | 279 | N/A | -79 | N/A |
| 3/31/2014 | 1,351 | 295 | N/A | 79 | N/A |
| 12/31/2013 | 1,311 | 267 | N/A | 54 | N/A |
| 9/30/2013 | 1,294 | 264 | N/A | 181 | N/A |
| 6/30/2013 | 1,299 | 262 | N/A | 174 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2070 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (14%).
Earnings vs Market: 2070 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 2070 is expected to become profitable in the next 3 years.
Revenue vs Market: 2070's revenue (10.2% per year) is forecast to grow faster than the SA market (0.4% per year).
High Growth Revenue: 2070's revenue (10.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2070's Return on Equity is forecast to be low in 3 years time (13.3%).